Substance / Medication

Recombinant human luteinizing hormone

Overview

Active Ingredient
lutropin alfa
RxNorm CUI
388084

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis.
Pérez-Milán F, Caballero-Campo M, Carrera-Roig M et al. · Ultrasound Obstet Gynecol · 2025
PMID: 38764191Meta-AnalysisFull text (PMC)
Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials.
Conforti Alessandro, Carbone Luigi, Di Girolamo Raffaella et al. · Fertil Steril · 2025
PMID: 39332623Meta-Analysis
Maternal and perinatal outcomes of live births after uterus transplantation: A systematic review.
Brännström Mats, Bokström Hans, Hagberg Henrik et al. · Acta Obstet Gynecol Scand · 2025
PMID: 39579025Meta-AnalysisFull text (PMC)
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.
Galati Giulia, Olivieri Carlotta, Cosentino Martina et al. · J Assist Reprod Genet · 2025
PMID: 39666211Meta-AnalysisFull text (PMC)
Prevalence of contrast intravasation in HyCoSy/HyFoSy. Results of a multicenter study and systematic review of the literature with meta-analysis.
Alcazar Juan Luis, Peñate Laura, Casanova Virgina et al. · Eur J Obstet Gynecol Reprod Biol · 2025
PMID: 39673914Meta-Analysis
Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibition in healthy men.
Takahashi Paul Y, Votruba Patrick, Abu-Rub Mohammed et al. · J Clin Endocrinol Metab · 2007
PMID: 17579202RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Lutropin alfa (substance)
SNOMED CT
415248001
UMLS CUI
C1271607
RxNorm CUI
388084

Clinical Data

This intervention maps to 7 entities in the Ltrl knowledge graph.

1
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.